From a molecular therapeutic viewpoint, Relafen 750 (nabumetone) represents a fascinating example of a non-copyrightal anti-inflammatory medication that undergoes significant conversion within the body. Its initial ingestion isn't directly responsible for its primary effect ; instead, it’s converted to its active metabolite, 6-methoxy-nabumetone